Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Sep 27:2018:7358472.
doi: 10.1155/2018/7358472. eCollection 2018.

The Venom of Spectacled Cobra (Elapidae: Naja naja): In Vitro Study from Distinct Geographical Origins in Sri Lanka

Duminda S B Dissanayake  1 , Lasanthika D Thewarage  1 , Roshitha N Waduge  2 , J G S Ranasinghe  3 , S A M Kularatne  4 , R P V Jayanthe Rajapakse  1
Affiliations

The Venom of Spectacled Cobra (Elapidae: Naja naja): In Vitro Study from Distinct Geographical Origins in Sri Lanka

Duminda S B Dissanayake et al. J Toxicol. .

Abstract

Several countries residing envenomation due to Naja naja had revealed a disparity in the venom composition according to their geographic location and Sri Lankan cobra still lacks the evidence to support this. Therefore, the current study was focused on addressing relationship between the histopathological changes according to geographic variation of Sri Lankan N. naja venom. The histopathological changes in vital organs and muscle tissues following intramuscular administration of venom of N. naja were studied using BALB/c mice. The median lethal dose of venom of N. naja in the present study was determined to be 0.55, 0.66, 0.68, 0.62, and 0.7 mg/kg for North (NRP), Central (CRP), Western, Southern, and Sabaragamuwa Regional Population venoms, respectively. Histopathological changes were observed in different levels in vital organs and muscle tissues of mice. NRP accompanied significantly higher infiltration of inflammatory and necrotic cells into skeletal muscle and CRP venom demonstrated high level of cardiotoxic effects comparing to other regions. This study revealed a certain extent of variations in the pathological effects of N. naja venom samples according to their geographical distribution.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Spectacled cobra (Naja naja); (a) distinct hood and (b) spectacle pattern on the hood.
Figure 2
Figure 2
The schematic representation of the collection localities of Indian cobra venom samples.
Figure 3
Figure 3
Histopathological changes in cardiac muscles, after 3hr from injection of N. naja venom from (a) Western Region Population, (b) Central Region Population, (c) North Region Population, (d) Sabaragamuwa Region Population, (e) Southern Region Population, and (f) Control. (A) Congestion. (B) Necrotic fibers. (C) Inflammations.
Figure 4
Figure 4
Histopathological changes in lung tissues, after 3hr from injection of N. naja venom from (a) Western Region Population, (b) Central Region Population, (c) North Region Population, (d) Sabaragamuwa Region Population, (e) Southern Region Population, and (f) Control. (A) Alveolar haemorrhages. (B) Interstitial septal widening.
Figure 5
Figure 5
Histopathological changes in kidney, after 3hr from injection of N. naja venom from (a) Western Region Population, (b) Central Region Population, (c) North Region Population, (d) Sabaragamuwa Region Population, (e) Southern Region Population, and (f) Control. (A) Acute tubular necrosis. (B) Congestion.
Figure 6
Figure 6
Histopathological changes in liver, after 3hr from injection of N. naja venom from (a) Western Region Population, (b) Central Region Population, (c) North Region Population, (d) Sabaragamuwa Region Population, (e) Southern Region Population, and (f) Control. (A) Lytic necrosis. (B) Hepatocyte degeneration. (C) Zonal hepatocellular necrosis.
Figure 7
Figure 7
Serum glutamate-oxaloacetate transaminase (SGOT) activity.
Figure 8
Figure 8
Serum glutamate-pyruvate transaminase (SGPT) activity.
Figure 9
Figure 9
Serum Creatine Kinase (CK) activity.
See this image and copyright information in PMC

References

    1. Kasturiratne A., Wickremasinghe A. R., de Silva N., et al. The global burden of snakebite: a literature analysis and modelling based on regional estimates of envenoming and deaths. PLoS Medicine. 2008;5(11) doi: 10.1371/journal.pmed.0050218. - DOI - PMC - PubMed
    1. Harrison R. A., Hargreaves A., Wagstaff S. C., Faragher B., Lalloo D. G. Snake envenoming: a disease of poverty. PLOS Neglected Tropical Diseases. 2009;3(12, article e569) doi: 10.1371/journal.pntd.0000569. - DOI - PMC - PubMed
    1. World Health Organization, WHO Guidelines for the Production, Control and Regulation of Snake Antivenom Immunoglobulins. World Health Organization, Geneva. 2010. http://www.who.int/bloodproducts/snake_antivenoms/snakeantivenomguide/en/
    1. Kasturiratne A., Pathmeswaran A., Fonseka M. M. D., Lalloo D. G., Brooker S., De Silva H. J. Estimates of disease burden due to land-snake bite in Sri Lankan hospitals. Southeast Asian Journal of Tropical Medicine and Public Health. 2005;36(3):733–740. - PubMed
    1. Kularatne K., Budagoda S., Maduwage K., Naser K., Kumarasiri R., Kularatne S. Parallels between Russell's viper (Daboia russelii) and hump-nosed viper (Hypnale species) bites in the central hills of Sri Lanka amidst the heavy burden of unidentified snake bites. Asian Pacific Journal of Tropical Medicine. 2011;4(7):564–567. doi: 10.1016/S1995-7645(11)60147-8. - DOI - PubMed